title: Industry, clinical trials, and the cost of cancer drugs: an investor's perspective.
authors.forename: Tony
authors.initials: T
authors.lastname: Fiorino
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000191:economics*; D003132:Commerce; D016265:Conflict of Interest; D003253:Consultants; D004345:Drug Industry / Q000191:economics*; D004995:Ethics, Professional; D005544:Forecasting; D006801:Humans; D007449:Investments; D008495:Medical Oncology / Q000191:economics*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents